AI-driven drug design
In developmentFirst focus: Alzheimer's disease
We are building an AI model for drug design, starting with Alzheimer's disease. The goal is to speed up early-stage drug discovery by helping researchers design and prioritise drug candidates faster.
- AI model for designing and prioritising drug candidates
- Alzheimer's disease as the first target
- Faster, iterative experiments with a small research team
